Federal health programs now cover STI testing free of charge
H.R. 9946 — Equity in STI Testing Act · Filed by Nikema Williams (D-GA) · 11 cosponsors · Introduced Jul 23, 2026 · Referred to committee
Your members of Congress
Enter a ZIP to see where your representative and both senators stood on this bill.
Looked up on this device — your ZIP is never stored on our servers.
What it does
This bill requires Medicare Advantage, Medicaid, CHIP, TRICARE, VA, and Indian Health Service to cover screening tests for five sexually transmitted infections (HIV, gonorrhea, syphilis, trichomoniasis, chlamydia) without charging patients any out-of-pocket costs. The bill applies the same preventive-service standard already used in private health insurance under the Affordable Care Act, extending it to federal health programs.
Why we flagged it
The bill's operative mechanism is a straightforward mandate to cover and fund a preventive health service (STI screening) across federal health programs, with no cost-sharing. It is a public-health measure, not a tax provision, appropriation rider, or industry carve-out.
What the text implies
- The bill ties STI testing coverage in federal programs to the ACA's private-insurance standard (section 2713(a)(1) of the Public Health Service Act), meaning changes to that private standard could indirectly affect federal program coverage.
- Medicaid and CHIP implementation requires state legislative action in some cases; the bill grants a one-year grace period for states to comply, potentially creating a patchwork of coverage timelines.
- The bill does not appropriate funds; it mandates coverage but leaves funding mechanisms to existing program budgets, which may require reallocation within Medicare Advantage, Medicaid, and other programs.
Section numbers refer to the bill text the analysis read — linked under Primary records below.
Who it affects
Ordinary people enrolled in federal health programs gain access to preventive STI testing without cost barriers, reducing financial obstacles to early detection and treatment of infections that can cause serious health complications if untreated. The bill removes a known barrier to preventive care (cost-sharing) for a medically important screening service.
Who stands to gain
- diagnostic testing laboratories and providers (increased volume of STI tests)
- public health agencies (reduced downstream costs from untreated infections)
Named in the bill
Medicare Advantage, Medicaid, CHIP (Children's Health Insurance Program), TRICARE, VA (Department of Veterans Affairs), Indian Health Service, HHS (Department of Health and Human Services), Social Security Act, Public Health Service Act
Where it stands
11 cosponsors: 11 Democrats.
- Jul 23, 2026 — Introduced · Congress.gov: “Introduced in House”
- Jul 23, 2026 — Referred to House Committee on Natural Resources and House Committee on Armed Services · Congress.gov: “Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means…”
Dates and quoted wording are Congress.gov's action record; the timeline shows status changes, not every procedural step.
How this was measured
Analysis — Quorum's AI read the bill text published by Congress.gov (12,397 characters) on Sep 21, 2026. Section numbers in the findings refer to that text, linked below; transparency and hidden-provision scores are compared against the median of 14,522 analysed bills.
Status and sponsors — Congress.gov's bill record — actions, committee referrals and cosponsors — loaded nightly. The timeline shows status changes, not every procedural action.
As of — page rendered 2026-09-21.
“Federal health programs now cover STI testing free of charge” QuorumCivic. https://share.quorumcivic.app/bill/119/hr9946 Report an error